polynovo signed contract sale aod9604 lateral pharma Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance Cancer R&D Partnerships, M&A and
Cancer R&D Partnerships, M&A and Venture Funding by Tech Q3 2025 Review DealForma Exclusives Archive Contract Pharma PharmNovo enhances its Board ahead of Phase II development PharmNovo AOD 9604 (10mg vials) Peptide Partners SN 1125 Memorandum of Land Sale Contract (OR)
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




